Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,450 total articles

Blockfusion and Blue Acquisition Corp. Announce LOIs for Anchor Lease with a Leading AI Customer and $175 Million Convertible Note Financing and Non-Redemption Agreement, and Advancement of Planned Expansion of Niagara Falls Campus

Blockfusion and Blue Acquisition Corp. Announce LOIs for Anchor Lease with a Leading AI Customer and $175 Million Convertible Note Financing and Non-Redemption Agreement, and Advancement of Planned Expansion of Niagara Falls Campus

Blockfusion USA and Blue Acquisition Corp. announced non-binding letters of intent for a 15-year, take-or-pay anchor lease of up to 300 MW with a leading AI customer at Blockfusion's Niagara Falls data center campus, complemented by a $175 million convertible note financing and non-redemption agreement. These moves support capitalizing and expandin…

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors

Palvella Therapeutics, a Nasdaq-listed clinical-stage biopharmaceutical company developing therapies for serious rare skin diseases and vascular malformations, appoints Matt Pauls, an experienced biotech executive and commercial leader, to its Board of Directors. This strategic appointment leverages Pauls' over 25 years of expertise in advancing ra…

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients

FocalTherics announced the launch of the first commercial endometriosis treatment program using its Focal One Robotic HIFU system at Toulouse University Hospital in France. This program marks a significant expansion of the company's minimally invasive therapy aimed at deep infiltrating endometriosis, a condition affecting approximately 38 million w…

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent

OptimizeRx Corp. announced the launch of CopayCue™, a next-generation tool integrating real-time prescribing intent data into the electronic prescribing workflow to make brand savings offers more transparent and accessible to healthcare providers and patients. This innovation aims to reduce cost barriers, increase prescription fulfillment rates, an…

InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos

Following the European Medicines Agency's recommendation to revoke Tavneos' marketing authorization for ANCA-associated vasculitis, InflaRx N.V. is assessing a broadened development strategy in Europe for its anti-C5a antibody vilobelimab and oral C5aR inhibitor izicopan. The company plans to engage with EMA to determine the most efficient path to …

Bilibili Inc. Provides Update on Share Repurchase Program

Bilibili Inc. Provides Update on Share Repurchase Program

Bilibili Inc. has announced an update on its share repurchase program, revealing it has repurchased approximately 1.9 million shares for $31.3 million as of June 30, 2026, and 4.8 million shares totaling $100.1 million over the past six months. This move reflects the company's strategy to enhance shareholder value and confidence in its growth prosp…

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)

Unicycive Therapeutics announced receipt of a Complete Response Letter from the FDA regarding the resubmitted New Drug Application for oxylanthanum carbonate (OLC), an investigational phosphate binder for hyperphosphatemia in dialysis patients. The FDA did not express concerns about clinical data, but the CRL stems from unresolved third-party manuf…

Aurora Mobile’s JPush Partners with CICC Wealth Management to Enhance the Digital Wealth Management Experience

Aurora Mobile’s JPush Partners with CICC Wealth Management to Enhance the Digital Wealth Management Experience

Aurora Mobile Limited (NASDAQ: JG) has partnered with China CICC Wealth Management to integrate its JPush intelligent push notification solution into the CICC Wealth Management App. This integration aims to improve the app's communication infrastructure, enhancing reliability, compliance, and personalization in delivering transaction alerts and adv…

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease

AC Immune Reports Interim 12-Month Data from Phase 1b/2 ABATE Trial of ACI-24 in Prodromal Alzheimer’s Disease

AC Immune reported interim 12-month data from the Phase 1b/2 ABATE trial of ACI-24, an anti-Abeta active immunotherapy for prodromal Alzheimer's disease. The treatment was generally safe and well tolerated across three patient cohorts, showing a clear dose-response in anti-Abeta antibody production. The ongoing fourth cohort is testing an enhanced …

Tilray Beer Brands SweetWater, 10 Barrel, Breckenridge, BrewDog, Montauk, Blue Point, Hop Valley and Terrapin Tap into America’s 250th with Fourth of July Celebrations Nationwide

Tilray Beer Brands SweetWater, 10 Barrel, Breckenridge, BrewDog, Montauk, Blue Point, Hop Valley and Terrapin Tap into America’s 250th with Fourth of July Celebrations Nationwide

Tilray Brands, Inc., through its U.S. beer division Tilray Beer, is hosting a nationwide series of Fourth of July events featuring its craft beer brands such as SweetWater, 10 Barrel, Breckenridge, BrewDog, Montauk, Blue Point, Hop Valley, and Terrapin. The celebrations will include live music, exclusive merchandise, special beer deals, and local e…

RUM Group Inc. Announces the Filing of Updated Investor Materials

RUM Group Inc. Announces the Filing of Updated Investor Materials

RUM Group Inc., a NASDAQ-listed company integrating video platform Rumble and AI infrastructure firm Quake AI, announced updated investor materials emphasizing significant GPU utilization increases, secured multi-year contracts worth $270 million for advanced NVIDIA GPU deployments at its Amsterdam data center, and a 50% reduction in debt facilitie…

Factorial Welcomes Shareholders with Letter Detailing a Decade of Solid-State Battery Innovation, Global Partnerships, and a Capital-Light Path to Commercialization

Factorial Welcomes Shareholders with Letter Detailing a Decade of Solid-State Battery Innovation, Global Partnerships, and a Capital-Light Path to Commercialization

Factorial Energy Inc., a U.S.-based solid-state battery innovator, published a shareholder letter summarizing its decade-long technology milestones, key OEM partnerships including Mercedes-Benz and Stellantis, and its capital-light manufacturing strategy post its June 8, 2026 Nasdaq listing. The company is positioned for growth amid rising demand f…

Solana Company Partners with Alatau City to Advance Digital Asset Infrastructure and Blockchain Adoption in Central Asia

Solana Company Partners with Alatau City to Advance Digital Asset Infrastructure and Blockchain Adoption in Central Asia

Solana Company (NASDAQ: HSDT) announced a strategic partnership with Alatau City administration to support the latter's development as a leading international center for digital assets and blockchain technology in Central Asia. The collaboration aims to leverage Solana's blockchain infrastructure and expertise to accelerate institutional blockchain…

Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion

Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerability, and Durable Clinical Activity in MEK/BRAF-Pretreated Patients, plus Protocol Expansion

Pasithea Therapeutics announced interim Phase 1 data for PAS-004, its next-generation oral MEK inhibitor, demonstrating a well-tolerated safety profile and durable disease stabilization in heavily pre-treated advanced cancer patients, including those who failed prior BRAF/MEK inhibitor treatments. The study continues with dose escalation and food e…

Eos Energy Enterprises, Inc. Announces Proposed Registered Direct Offering of Common Stock and Warrants to Fund Investment in Frontier Power USA

Eos Energy Enterprises, Inc. Announces Proposed Registered Direct Offering of Common Stock and Warrants to Fund Investment in Frontier Power USA

Eos Energy Enterprises, Inc. announced a registered direct offering of common stock and warrants to raise capital for funding its investment in Frontier Power USA. The offering is subject to market conditions and other closing requirements. The company aims to leverage proceeds from this and a proposed rights offering to support its contribution to…

Inseego Advances International Expansion with New Regional Leadership, International Headquarters, and Continued Investment in Athens Software Development Center

Inseego Advances International Expansion with New Regional Leadership, International Headquarters, and Continued Investment in Athens Software Development Center

Inseego Corp. announces strategic moves to advance its international growth including key regional leadership appointments in APAC and EMEA, expanded sales leadership in the Americas, establishing Amsterdam as its international headquarters, and investing in its Athens software development center. These initiatives support its planned acquisition o…